A pharmacist might remove an ingredient that causes an allergy, turn a pill into a liquid for a child or produce a dosage that is not commercially available
BPC-157 is not approved by any drug regulatory agency for human use, and there is limited data regarding its effectiveness on humans
Computational prioritization of T cell epitopes to overcome HLA restriction and antigenic diversity in plasmodium falciparum
Originally characterized by the Sikiric group at the University of Zagreb School of Medicine, BPC-157 is unusual among peptides for its reported oral activity attributed to its origin in gastric juice, which suggests evolutionary adaptation to the digestive environment
carrier, package, container, vial, and/or tube labels listing contents and/or instructions for use, and package inserts with instructions for use
Target: Reach about 250300 mcg daily by Weeks 48